Antioxidant Status, Lipoprotein Profile and Liver Lipids in
Rats Fed on High-Cholesterol Diet Containing Currant Oil Rich in
n-3 and n-6 Polyunsaturated Fatty Acids
R. VEČEŘA1, N. ŠKOTTOVÁ1,
P. VÁŇA1, L. KAZDOVÁ2, Z. CHMELA3,
Z. ŠVAGERA4, D. WALTEROVÁ4, J.
ULRICHOVÁ4, V. ŠIMÁNEK4
1Institute of Pharmacology, Medical Faculty, Palacký University,
Olomouc, 2Institute of Experimental and Clinical Medicine, Prague,
3Institute of Pathological Physiology, Medical Faculty, Palacký
University, Olomouc, and 4Institute of Medical Chemistry, Medical
Faculty, Palacký University, Olomouc, Czech Republic
Received March 13, 2002
Accepted June 7, 2002
Summary
Plant-based n-3 polyunsaturated fatty acids (PUFA) possess a
prospective antiatherogenic potential. Currant oil from Ribes
nigrum L. is one of the few plant oils containing PUFAn-3 (15.3
mol%) in addition to PUFAn-6 (60.5 mol%). This study was aimed
at comparing the effects of currant oil with those of lard fat,
rich in saturated (43.8 mol%) and monounsaturated (47.0 mol%)
fatty acids, on antioxidant parameters, the lipoprotein profile
and liver lipids in rats fed on 1 % (w/w) cholesterol diets
containing either 10 % of currant oil (COD) or lard fat (LFD).
After 3 weeks of feeding, the COD induced a significant decrease
in blood glutathione (GSH) and an increase in Cu2+ induced
oxidizability of serum lipids, but did not affect liver GSH and
t-butyl hydroperoxide-induced lipoperoxidation of liver
microsomes. Although the COD did not cause accumulation of liver
triacylglycerols as LFD, the lipoprotein profile (VLDL, LDL, HDL)
was not significantly improved after COD. The consumption of
PUFAn-3 was reflected in LDL as an increase in eicosapentaenoic
and docosahexaenoic acid. These results suggest that currant oil
affects positively the lipid metabolism in the liver, above all
it does not cause the development of a fatty liver. However,
adverse effects of currant oil on the antioxidant status in the
blood still remain of concern.
Key
words
Polyunsaturated fatty acids • Currant oil • Antioxidant
status • Lipoprotein profile • Liver lipids
Reprint
requests
Nina Škottová, Institute of Pharmacology, Medical Faculty,
Palacký University, Hněvotínská 3, 775 15 Olomouc, Czech
Republic. E-mail:
Nina@tunw.upol.cz
|